Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons (2010)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- Subjects: FOSFOLIPASES A (ANÁLISE); NEURÔNIOS (IMUNOLOGIA); DOENÇA DE ALZHEIMER (DIAGNÓSTICO); WESTERN BLOTTING; RESUMOS (EVENTOS)
- Language: Inglês
- Imprenta:
- Source:
- Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP"
-
ABNT
PAULA, V J R de et al. Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 24 abr. 2024. , 2010 -
APA
Paula, V. J. R. de, Talib, L. L., Bigelli, V., Gattaz, W. F., & Forlenza, O. V. (2010). Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Paula VJR de, Talib LL, Bigelli V, Gattaz WF, Forlenza OV. Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons. Clinics. 2010 ; 65 S36-S37.[citado 2024 abr. 24 ] -
Vancouver
Paula VJR de, Talib LL, Bigelli V, Gattaz WF, Forlenza OV. Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons. Clinics. 2010 ; 65 S36-S37.[citado 2024 abr. 24 ] - Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study
- A radioenzymatic assay to identify three groups of phospholipase A2 in platelets
- Interleukin-1β Serum Levels is Increased in Antidepressant-Free Elderly Depressed Patients
- Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study
- Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study
- Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer’s disease patients
- Long-Term Lithium Treatment Increases cPLA2 and iPLA2 Activity in Cultured Cortical and Hippocampal Neurons
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
